145 related articles for article (PubMed ID: 19855243)
1. Suppression of hepatocellular carcinoma recurrence after rat liver transplantation by FTY720, a sphingosine-1-phosphate analog.
Ushitora Y; Tashiro H; Ogawa T; Tanimoto Y; Kuroda S; Kobayashi T; Miyata Y; Itamoto T; Asahara T; Ohdan H
Transplantation; 2009 Oct; 88(8):980-6. PubMed ID: 19855243
[TBL] [Abstract][Full Text] [Related]
2. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP
Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267
[TBL] [Abstract][Full Text] [Related]
3. Marked suppression of tumor growth by FTY720 in a rat liver tumor model: the significance of down-regulation of cell survival Akt pathway.
Ng KT; Man K; Ho JW; Sun CK; Lee TK; Zhao Y; Lo CM; Poon RT; Fan ST
Int J Oncol; 2007 Feb; 30(2):375-80. PubMed ID: 17203219
[TBL] [Abstract][Full Text] [Related]
4. FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma.
Lee TK; Man K; Ho JW; Wang XH; Poon RT; Xu Y; Ng KT; Chu AC; Sun CK; Ng IO; Sun HC; Tang ZY; Xu R; Fan ST
Clin Cancer Res; 2005 Dec; 11(23):8458-66. PubMed ID: 16322309
[TBL] [Abstract][Full Text] [Related]
5. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1.
Schmid G; Guba M; Ischenko I; Papyan A; Joka M; Schrepfer S; Bruns CJ; Jauch KW; Heeschen C; Graeb C
J Cell Biochem; 2007 May; 101(1):259-70. PubMed ID: 17203465
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine 1-phosphate receptor expression profile in human gastric cancer cells: differential regulation on the migration and proliferation.
Yamashita H; Kitayama J; Shida D; Yamaguchi H; Mori K; Osada M; Aoki S; Yatomi Y; Takuwa Y; Nagawa H
J Surg Res; 2006 Jan; 130(1):80-7. PubMed ID: 16183075
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.
LaMontagne K; Littlewood-Evans A; Schnell C; O'Reilly T; Wyder L; Sanchez T; Probst B; Butler J; Wood A; Liau G; Billy E; Theuer A; Hla T; Wood J
Cancer Res; 2006 Jan; 66(1):221-31. PubMed ID: 16397235
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
[TBL] [Abstract][Full Text] [Related]
9. The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology.
von Wenckstern H; Zimmermann K; Kleuser B
Arch Immunol Ther Exp (Warsz); 2006; 54(4):239-51. PubMed ID: 16830220
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-phosphate and FTY720 as anti-atherosclerotic lipid compounds.
Tölle M; Levkau B; Kleuser B; van der Giet M
Eur J Clin Invest; 2007 Mar; 37(3):171-9. PubMed ID: 17359484
[TBL] [Abstract][Full Text] [Related]
11. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
Chiba K; Matsuyuki H; Maeda Y; Sugahara K
Cell Mol Immunol; 2006 Feb; 3(1):11-9. PubMed ID: 16549044
[TBL] [Abstract][Full Text] [Related]
12. Cytoprotective Actions of FTY720 Modulate Severe Preservation Reperfusion Injury in Rat Renal Transplants.
Fuller TF; Hoff U; Kong L; Naether M; Wagner P; Nieminen-Kelhä M; Nolting J; Luft FC; Hegner B; Dragun D
Transplantation; 2010 Feb; 89(4):402-8. PubMed ID: 20177341
[TBL] [Abstract][Full Text] [Related]
13. FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling.
Hung JH; Lu YS; Wang YC; Ma YH; Wang DS; Kulp SK; Muthusamy N; Byrd JC; Cheng AL; Chen CS
Cancer Res; 2008 Feb; 68(4):1204-12. PubMed ID: 18281497
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
Walter DH; Rochwalsky U; Reinhold J; Seeger F; Aicher A; Urbich C; Spyridopoulos I; Chun J; Brinkmann V; Keul P; Levkau B; Zeiher AM; Dimmeler S; Haendeler J
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):275-82. PubMed ID: 17158356
[TBL] [Abstract][Full Text] [Related]
15. FTY720 inhibits S1P-mediated endothelial healing: relationship to S1P1-receptor surface expression.
Krump-Konvalinkova V; Chwalla I; Siess W
Biochem Biophys Res Commun; 2008 Jun; 370(4):603-8. PubMed ID: 18402775
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology.
Brinkmann V
Pharmacol Ther; 2007 Jul; 115(1):84-105. PubMed ID: 17561264
[TBL] [Abstract][Full Text] [Related]
17. Effect of FTY720 and ex vivo graft irradiation in rat small bowel transplantation: apoptosis of crypt cells and lymphocytes.
Sugito K; Inoue M; Ikeda T; Hagiwara N; Koshinaga T; Kusafuka T
Transplant Proc; 2007 Dec; 39(10):3432-5. PubMed ID: 18089399
[TBL] [Abstract][Full Text] [Related]
18. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
Chiba K
Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
[TBL] [Abstract][Full Text] [Related]
19. Effect of FTY720 in rat small bowel transplantation: apoptosis of crypt cells and lymphocytes in gut-associated lymphoid tissues.
Sugito K; Koshinaga T; Inoue M; Ikeda T; Hagiwara N; Kusafuka T; Fukuzawa M
Transplant Proc; 2006 Nov; 38(9):3058-60. PubMed ID: 17112899
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment.
Azuma H; Takahara S; Horie S; Muto S; Otsuki Y; Katsuoka Y
J Urol; 2003 Jun; 169(6):2372-7. PubMed ID: 12771800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
